| Open Price | 108.35 | Shares Traded | 237870 |
| High Price | 113.40 | 52 Wk High | 193.95 |
| Low Price | 106.80 | 52 Wk Low | 80.35 |
| Previous Close | 110.15 | Face Value | 1.00 |
| 52 Wk High Date | 23-05-2011 | 52 Wk Low Date | 18-11-2011 |
| Open Price | 109.15 | Shares Traded | 1059760 |
| High Price | 113.30 | 52 Wk High | 193.00 |
| Low Price | 107.15 | 52 Wk Low | 80.15 |
| Previous Close | 110.15 | Face Value | 1.00 |
| 52 Wk High Date | 23-05-2011 | 52 Wk Low Date | 18-11-2011 |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| Year End | Dec, 2011 | Dec, 2011 | Mar, 2011 |
| Sales (Rs.cr) | 1201.50 | 4197.48 | 4082.70 |
| Net Profit (Rs.cr) | 12.93 | 322.79 | 614.83 |
| Net Profit Var (%) | -94.00 | -46.00 | 19.00 |
| EPS (Rs) | - | 20.80 | |
| P/E Ratio | - | 9.92 | 5.30 |
| Operating Profit Margin | - | 14.95 | - |
| CPS (Rs.) | - | - | 25.10 |
| P/C Ratio | - | - | 4.40 |
| Div% | - | - | 200.00 |
| Related Companies | ||
| Stock Name | Price | |
| CIPLA | 309.20 | |
| JBCHEPHARM | 63.70 | |
| PIRHEALTH | 419.60 | |
| RANBAXY | 501.10 | |
| UNICHEMLAB | 131.80 | |
| ALEMBICLTD | 15.50 | |
| LYKALABS | 9.60 | |
| TTKHEALTH | 361.85 | |
| DRREDDY | 1,675.60 | |
| SOLPHARMA | 9.65 | |
| Fundamentals | |
| Market Capital (Rs.cr) | 3206.47 |
| EPS (Rs.)(TTM) | |
| P/E Ratio(TTM) | 9.92 |
| Book Value (Rs.) | 88.30 |
| Price to Book Value | 1.25 |
| Equity (Rs.cr.) | 29.11 |
| Traded Value (Rs.lac) | 212.35 |
| Announcements | |
| 11-02-2012 | Aurobindo Pharma adjourns board meeting |
| 30-12-2010 | Aurobindo Pharma allots equity shares |
| 19-01-2012 | Aurobindo Pharma appoints additional director |
| 03-11-2010 | Aurobindo Pharma declares interim dividend |
| 07-09-2011 | Aurobindo Pharma establishes a joint venture company with Diod (Russia) |
| 06-12-2011 | Aurobindo Pharma gets UK MHRA nod for the Bisoprol Fumarate tablets |
| 25-11-2011 | Aurobindo Pharma gets UK MHRA nod for the Cefpodoxime Proxetil tablets |
| 16-12-2011 | Aurobindo Pharma grants options |
| 21-11-2011 | Aurobindo Pharma received final approval for the Lamivudine tablets |
| 18-05-2011 | Aurobindo Pharma receives approvals for Risperidone tablets, oral solution & Alendronate tablets fr |
| 16-05-2012 | Aurobindo Pharma receives final approval for Lamivudine & Zidovudine tablets |
| 26-04-2012 | Aurobindo Pharma receives final approval for Olanzapine Tablets |
| 29-03-2012 | Aurobindo Pharma receives final approvals for Quetiapine Fumarate tablets |
| 09-05-2012 | Aurobindo Pharma to announce financial results |
| 27-07-2011 | Aurobindo Pharma to announce Q1 results |
| 31-10-2011 | Aurobindo Pharma to announce Q2 results |
| 25-01-2011 | Aurobindo Pharma to announce Q3 results |
| 21-05-2012 | Aurobindo Pharma to consider dividend |
| 29-10-2010 | Aurobindo Pharma to consider interim dividend |
| 26-11-2010 | Aurobindo Pharma to convene EGM |
| Gross Deliverables | |||||
| Date | Del. Shares | Trd. Qty. | Del.(%) | Del. Value | Turnover |
| 15-05-2012 | 22525 | 108902 | 20.68 | 2393281 | 11,433.70 |
| 11-05-2012 | 40282 | 137618 | 29.27 | 4398794 | 15,142.00 |
| 09-05-2012 | 25835 | 101819 | 25.37 | 3018820 | 12,110.20 |
| 08-05-2012 | 18076 | 83140 | 21.74 | 2237809 | 10,301.50 |
| 04-05-2012 | 20965 | 76608 | 27.37 | 2525234 | 9,349.94 |
